glaxo smith kline

Consumer Reports Dissects Ad For Restless Leg Syndrome Drug Requip

Consumer Reports Dissects Ad For Restless Leg Syndrome Drug Requip

Consumer Reports deconstructs the ad for “restless leg syndrome” drug Requip in this amusing video. Restless Leg Syndrome, while a real condition, affects less than 3% of adults, but the ad offers a vague enough definition that it could apply to anyone. The ad does warn against some of the side effects, like nausea, diarrhea, drowsiness while driving and increased gambling and sexual urges. Consumer Reports tells us that in one Mayo clinic study, two people with no previous gambling history took it and subsequently went to lose over $100,000 in gambling. But, hey, at least their legs weren’t restless underneath the roulette table.